DENTSPLY SIRONA Inc. (XRAY)
USD 12.66
(-4.38%)
USD 12.66
(-4.38%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.79 Billion USD | -9.06% |
| 2022 | 1.97 Billion USD | -4.03% |
| 2021 | 2.05 Billion USD | -2.37% |
| 2020 | 2.1 Billion USD | 35.77% |
| 2019 | 1.55 Billion USD | -0.79% |
| 2018 | 1.56 Billion USD | -2.9% |
| 2017 | 1.61 Billion USD | 6.65% |
| 2016 | 1.51 Billion USD | 32.44% |
| 2015 | 1.14 Billion USD | -1.03% |
| 2014 | 1.15 Billion USD | -1.14% |
| 2013 | 1.16 Billion USD | -4.57% |
| 2012 | 1.22 Billion USD | -17.98% |
| 2011 | 1.49 Billion USD | 146.68% |
| 2010 | 604.01 Million USD | 56.02% |
| 2009 | 387.15 Million USD | -8.62% |
| 2008 | 423.67 Million USD | -12.11% |
| 2007 | 482.06 Million USD | 31.29% |
| 2006 | 367.16 Million USD | 35.93% |
| 2005 | 270.1 Million USD | -65.37% |
| 2004 | 779.94 Million USD | -1.3% |
| 2003 | 790.2 Million USD | 2.65% |
| 2002 | 769.82 Million USD | 6.4% |
| 2001 | 723.52 Million USD | 560.75% |
| 2000 | 109.5 Million USD | -24.64% |
| 1999 | 145.3 Million USD | -33.2% |
| 1998 | 217.5 Million USD | 106.16% |
| 1997 | 105.5 Million USD | 40.48% |
| 1996 | 75.1 Million USD | 9.32% |
| 1995 | 68.7 Million USD | 436.72% |
| 1994 | 12.8 Million USD | -86.58% |
| 1993 | 95.4 Million USD | 844.55% |
| 1992 | 10.1 Million USD | -54.09% |
| 1991 | 22 Million USD | 285.96% |
| 1990 | 5.7 Million USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.74 Billion USD | -2.73% |
| 2024 Q2 | 1.73 Billion USD | -0.57% |
| 2023 Q3 | 1.93 Billion USD | -2.47% |
| 2023 Q4 | 1.79 Billion USD | -7.23% |
| 2023 Q1 | 1.98 Billion USD | 0.56% |
| 2023 Q2 | 1.98 Billion USD | -0.05% |
| 2023 FY | 1.79 Billion USD | -9.06% |
| 2022 Q4 | 1.97 Billion USD | 4.44% |
| 2022 Q1 | 2.02 Billion USD | -1.41% |
| 2022 Q3 | 1.89 Billion USD | -3.81% |
| 2022 Q2 | 1.96 Billion USD | -3.1% |
| 2022 FY | 1.97 Billion USD | -4.03% |
| 2021 Q1 | 2.04 Billion USD | -2.85% |
| 2021 Q4 | 2.05 Billion USD | -0.29% |
| 2021 Q3 | 2.06 Billion USD | -1.01% |
| 2021 FY | 2.05 Billion USD | -2.37% |
| 2021 Q2 | 2.08 Billion USD | 1.81% |
| 2020 Q2 | 2.28 Billion USD | 49.31% |
| 2020 Q3 | 2.03 Billion USD | -10.87% |
| 2020 Q4 | 2.1 Billion USD | 3.57% |
| 2020 FY | 2.1 Billion USD | 35.77% |
| 2020 Q1 | 1.52 Billion USD | -1.49% |
| 2019 FY | 1.55 Billion USD | -0.79% |
| 2019 Q4 | 1.55 Billion USD | 1.98% |
| 2019 Q2 | 1.56 Billion USD | -6.58% |
| 2019 Q3 | 1.52 Billion USD | -2.45% |
| 2019 Q1 | 1.67 Billion USD | 6.75% |
| 2018 Q3 | 1.57 Billion USD | -0.74% |
| 2018 Q2 | 1.58 Billion USD | -3.58% |
| 2018 Q1 | 1.64 Billion USD | 2.1% |
| 2018 Q4 | 1.56 Billion USD | -0.63% |
| 2018 FY | 1.56 Billion USD | -2.9% |
| 2017 Q1 | 1.52 Billion USD | 1.13% |
| 2017 FY | 1.61 Billion USD | 6.65% |
| 2017 Q4 | 1.61 Billion USD | 0.68% |
| 2017 Q3 | 1.6 Billion USD | 0.84% |
| 2017 Q2 | 1.58 Billion USD | 3.87% |
| 2016 Q4 | 1.51 Billion USD | -3.74% |
| 2016 Q3 | 1.56 Billion USD | 33.96% |
| 2016 Q1 | 1.16 Billion USD | 2.46% |
| 2016 FY | 1.51 Billion USD | 32.44% |
| 2016 Q2 | 1.17 Billion USD | 0.23% |
| 2015 Q2 | 1.07 Billion USD | -0.1% |
| 2015 Q1 | 1.07 Billion USD | -6.42% |
| 2015 FY | 1.14 Billion USD | -1.03% |
| 2015 Q4 | 1.14 Billion USD | 62.56% |
| 2015 Q3 | 701.9 Million USD | -34.88% |
| 2014 Q1 | 1.06 Billion USD | -8.64% |
| 2014 Q3 | 1.16 Billion USD | 9.35% |
| 2014 FY | 1.15 Billion USD | -1.14% |
| 2014 Q4 | 1.15 Billion USD | -1.09% |
| 2014 Q2 | 1.06 Billion USD | 0.04% |
| 2013 Q4 | 1.16 Billion USD | 0.12% |
| 2013 Q1 | 1.2 Billion USD | -1.17% |
| 2013 Q2 | 1.12 Billion USD | -6.95% |
| 2013 Q3 | 1.16 Billion USD | 3.65% |
| 2013 FY | 1.16 Billion USD | -4.57% |
| 2012 FY | 1.22 Billion USD | -17.98% |
| 2012 Q1 | 1.48 Billion USD | -0.59% |
| 2012 Q2 | 1.48 Billion USD | 0.11% |
| 2012 Q3 | 1.23 Billion USD | -16.56% |
| 2012 Q4 | 1.22 Billion USD | -1.23% |
| 2011 FY | 1.49 Billion USD | 146.68% |
| 2011 Q4 | 1.49 Billion USD | -16.94% |
| 2011 Q3 | 1.79 Billion USD | 173.94% |
| 2011 Q2 | 654.87 Million USD | 0.4% |
| 2011 Q1 | 652.29 Million USD | 7.99% |
| 2010 Q3 | 592.37 Million USD | 27.95% |
| 2010 Q2 | 462.97 Million USD | 1.18% |
| 2010 FY | 604.01 Million USD | 56.02% |
| 2010 Q4 | 604.01 Million USD | 1.96% |
| 2010 Q1 | 457.56 Million USD | 18.19% |
| 2009 Q1 | 460.84 Million USD | 8.77% |
| 2009 Q3 | 154.84 Million USD | 6.09% |
| 2009 Q4 | 387.15 Million USD | 150.03% |
| 2009 FY | 387.15 Million USD | -8.62% |
| 2009 Q2 | 145.94 Million USD | -68.33% |
| 2008 Q2 | 576.64 Million USD | -1.73% |
| 2008 Q3 | 401.68 Million USD | -30.34% |
| 2008 Q4 | 423.67 Million USD | 5.48% |
| 2008 FY | 423.67 Million USD | -12.11% |
| 2008 Q1 | 586.81 Million USD | 21.73% |
| 2007 FY | 482.06 Million USD | 31.29% |
| 2007 Q1 | 413.35 Million USD | 12.58% |
| 2007 Q2 | 397.12 Million USD | -3.93% |
| 2007 Q4 | 482.06 Million USD | -2.74% |
| 2007 Q3 | 495.66 Million USD | 24.81% |
| 2006 Q1 | 186.86 Million USD | -30.82% |
| 2006 Q2 | 413.3 Million USD | 121.18% |
| 2006 Q3 | 329.2 Million USD | -20.35% |
| 2006 Q4 | 367.16 Million USD | 11.53% |
| 2006 FY | 367.16 Million USD | 35.93% |
| 2005 Q1 | 700.9 Million USD | -10.13% |
| 2005 FY | 270.1 Million USD | -65.37% |
| 2005 Q3 | 684.6 Million USD | 4.03% |
| 2005 Q4 | 270.1 Million USD | -60.55% |
| 2005 Q2 | 658.07 Million USD | -6.11% |
| 2004 FY | 779.94 Million USD | -1.3% |
| 2004 Q1 | 787.46 Million USD | -0.35% |
| 2004 Q2 | 771.34 Million USD | -2.05% |
| 2004 Q3 | 781.96 Million USD | 1.38% |
| 2004 Q4 | 779.94 Million USD | -0.26% |
| 2003 FY | 790.2 Million USD | 2.65% |
| 2003 Q4 | 790.2 Million USD | 0.87% |
| 2003 Q3 | 783.39 Million USD | -5.04% |
| 2003 Q2 | 824.97 Million USD | 3.43% |
| 2003 Q1 | 797.62 Million USD | 3.61% |
| 2002 Q2 | 786.17 Million USD | 8.27% |
| 2002 FY | 769.82 Million USD | 6.4% |
| 2002 Q1 | 726.12 Million USD | 0.36% |
| 2002 Q4 | 769.82 Million USD | -0.41% |
| 2002 Q3 | 772.95 Million USD | -1.68% |
| 2001 Q3 | 343.15 Million USD | 0.89% |
| 2001 Q1 | 272.33 Million USD | 148.7% |
| 2001 FY | 723.52 Million USD | 560.75% |
| 2001 Q2 | 340.11 Million USD | 24.89% |
| 2001 Q4 | 723.52 Million USD | 110.85% |
| 2000 Q4 | 109.5 Million USD | -3.02% |
| 2000 Q2 | 121.23 Million USD | -9.64% |
| 2000 Q1 | 134.16 Million USD | -7.67% |
| 2000 FY | 109.5 Million USD | -24.64% |
| 2000 Q3 | 112.9 Million USD | -6.87% |
| 1999 FY | 145.3 Million USD | -33.2% |
| 1999 Q3 | 170.4 Million USD | -8.44% |
| 1999 Q4 | 145.3 Million USD | -14.73% |
| 1999 Q1 | 197.6 Million USD | -9.15% |
| 1999 Q2 | 186.1 Million USD | -5.82% |
| 1998 Q2 | 171.7 Million USD | 44.29% |
| 1998 Q4 | 217.5 Million USD | 21.78% |
| 1998 Q3 | 178.6 Million USD | 4.02% |
| 1998 Q1 | 119 Million USD | 12.8% |
| 1998 FY | 217.5 Million USD | 106.16% |
| 1997 FY | 105.5 Million USD | 40.48% |
| 1997 Q1 | 131.2 Million USD | 74.7% |
| 1997 Q2 | 121.9 Million USD | -7.09% |
| 1997 Q3 | 115.5 Million USD | -5.25% |
| 1997 Q4 | 105.5 Million USD | -8.66% |
| 1996 Q1 | 121.1 Million USD | 76.27% |
| 1996 FY | 75.1 Million USD | 9.32% |
| 1996 Q2 | 105.7 Million USD | -12.72% |
| 1996 Q3 | 96 Million USD | -9.18% |
| 1996 Q4 | 75.1 Million USD | -21.77% |
| 1995 Q3 | 90.1 Million USD | -4.05% |
| 1995 Q2 | 93.9 Million USD | 201.93% |
| 1995 FY | 68.7 Million USD | 436.72% |
| 1995 Q4 | 68.7 Million USD | -23.75% |
| 1995 Q1 | 31.1 Million USD | 142.97% |
| 1994 FY | 12.8 Million USD | -86.58% |
| 1994 Q1 | 79.3 Million USD | -16.88% |
| 1994 Q2 | 65 Million USD | -18.03% |
| 1994 Q3 | 49.4 Million USD | -24.0% |
| 1994 Q4 | 12.8 Million USD | -74.09% |
| 1993 Q3 | 177.1 Million USD | -3.38% |
| 1993 FY | 95.4 Million USD | 844.55% |
| 1993 Q1 | 7.9 Million USD | -38.28% |
| 1993 Q2 | 183.3 Million USD | 2220.25% |
| 1993 Q4 | 95.4 Million USD | -46.13% |
| 1992 Q2 | 10.1 Million USD | 0.0% |
| 1992 Q3 | 10 Million USD | -0.99% |
| 1992 Q1 | 10.1 Million USD | 0.0% |
| 1992 FY | 10.1 Million USD | -54.09% |
| 1992 Q4 | 12.8 Million USD | 28.0% |
| 1991 Q2 | 25.8 Million USD | 17.27% |
| 1991 FY | 22 Million USD | 285.96% |
| 1991 Q3 | 21.7 Million USD | -15.89% |
| 1991 Q4 | 10.1 Million USD | -53.46% |
| 1991 Q1 | 22 Million USD | -41.49% |
| 1990 Q1 | 5.7 Million USD | -13.64% |
| 1990 FY | 5.7 Million USD | 0.0% |
| 1990 Q2 | - USD | -100.0% |
| 1990 Q3 | 37.3 Million USD | 0.0% |
| 1990 Q4 | 37.6 Million USD | 0.8% |
| 1989 Q1 | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| 1989 Q3 | 7 Million USD | 0.0% |
| 1989 Q2 | 7 Million USD | 0.0% |
| 1989 Q4 | 6.6 Million USD | -5.71% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | -2286.584% |
| AngioDynamics, Inc. | 3.93 Million USD | -45495.329% |
| AtriCure, Inc. | 60.59 Million USD | -2864.039% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | -2871.739% |
| BioLife Solutions, Inc. | 18.31 Million USD | -9708.312% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 28.837% |
| Daxor Corporation | 755.65 Thousand USD | -237573.342% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | -37068.874% |
| Femasys Inc. | 4.25 Million USD | -42077.654% |
| GlucoTrack, Inc. | 196 Thousand USD | -916226.531% |
| Harvard Bioscience, Inc. | 30.7 Million USD | -5749.401% |
| Hologic, Inc. | 2.49 Billion USD | 28.077% |
| ICU Medical, Inc. | 1.57 Billion USD | -13.832% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 2287.576% |
| KORU Medical Systems, Inc. | 3.65 Million USD | -49066.106% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | -10703.657% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | -106.034% |
| Microbot Medical Inc. | 40 Thousand USD | -4489900.0% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -39111398.258% |
| Merit Medical Systems, Inc. | 823.01 Million USD | -118.223% |
| Nephros, Inc. | 1.39 Million USD | -129108.633% |
| NovoCure Limited | 596.24 Million USD | -201.22% |
| NEXGEL, Inc. | 513 Thousand USD | -349997.466% |
| NEXGEL, Inc. | 513 Thousand USD | -349997.466% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | -2559.795% |
| OraSure Technologies, Inc. | 11.38 Million USD | -15670.987% |
| Pro-Dex, Inc. | 7.53 Million USD | -23732.272% |
| Pulse Biosciences, Inc. | 8.08 Million USD | -22111.229% |
| Predictive Oncology Inc. | 2.18 Million USD | -81947.384% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -92574.293% |
| QuidelOrtho Corporation | 2.27 Billion USD | 21.034% |
| Repligen Corporation | 510.14 Million USD | -252.058% |
| Sanara MedTech Inc. | 9.11 Million USD | -19607.843% |
| STAAR Surgical Company | 31.46 Million USD | -5607.567% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -608713.559% |
| Jin Medical International Ltd. | - USD | -Infinity% |